the years 1950 to 1954. These are assessed for survival at two years and also for primary recurrence at two years or at death within that period. The results are given in Tables I and  II . From the figures of primary recurrence In order that the present position may be understood fully, it is of advantage to summarize the way in which cancer of the middle ear has been treated in the past at the Christie Hospital. From 1932 From -1937 , the middle ear was exposed at operation and a radium tube of 2 to 5 mg inserted. A dose as high as 5,500 r at 1 cm from the tube was achieved, but the fall off in dose beyond this distance was so rapid that it was impossible to irradiate a sufficiently large volume. This disadvantage was overcome by the use of multifield beam directed X-rays of 250 or 500 kV, and the majority of patients have been treated in this way. One dominant field was balanced by four to six contralateral fields. A tumour dose of 5,000-5,500 r was given in three weeks, or its equivalent dose in five weeks. Better results were obtained by the lower than by the higher of these two dose levels.
Boden (1950) reported a few patients in whom late radiation damage to the brain-stem occurred after treatments of this kind. In 7 patients with damage, the dose in the brain-stem from small fields was between 4,500 and 6,050 r in three weeks. He suggested that 4,500 r in three weeks was the upper limit of safety in the brain-stem.
The middle ear being a cavity in bone made the use of harder radiation desirable, and some patients were later treated by a 10-g radium beam unit. A cluster of three fields from the affected side gave a tumour dose of 4,800-5,500 r in three weeks. Unfortunately, the percentage depth doses from the 10-g beam are low and it was difficult to attain a sufficiently high dose in the deepest part of the irradiated zone.
The physical characteristics of 4 MV X-rays are such as to overcome all the disadvantages of these previous methods. Because of the quality of the beam there is very little differential absorption in bone, while the high percentage depth doses ensure adequate radiation of the whole of the treated volume. In addition, the treatment is made more tolerable by the mild skin reactions. For these reasons, and because the number of patients seen is so small, a trial series by random selection to compare the results of conventional X-rays or radium beam with those of supervoltage was not undertaken when the 4 MV linear accelerator came to be used clinically. Rather it was decided that all cases deemed suitable for radical treatment should be treated by this 4 MV machine. This policy has been consistently followed since then.
Technique.-The technique of treatment on the linear accelerator remains essentially un-changed from that by beam directed X-rays of conventional levels. The history, the findings of the surgeon at operation (if anything more than a biopsy has been done), a clinical examination and radiographs all contribute information as to the position and spread of the tumour. Nevertheless, it must be admitted that in the majority of cases it is impossible to localize the tumour with exactitude, particularly as the spread in bone may not be apparent radiographically. Moreover, many of these patients have chronic middle-ear infections which make radiological diagnosis difficult. For this reason the treated volume must be larger than may seem at first necessary and, at a minimum, the whole of the petrous temporal bone is included.
The technique of beam direction itself is here described in outline only. A Perspex shell is fitted to the patient's head. The volume to be treated is chosen and localized with radiographs in respect to the shell. Verification films check the final position. Field selection follows on this. Three fields are found to give an ideal dose distribution. One homolateral field directed along the axis of the petrous temporal bone is balanced by contralateral submandibular and temporal fields. This arrangement enables the whole of the petrous temporal bone to be included in the treated volume while the midbrain lies posterior and is spared. In order that the skin dose is as low as possible, the Perspex is cut away coincident with the entrance beams. However, if the tumour involves skin or has grown to the external auditory meatus, it is necessary to build up the whole or part of the dominant field with wax of 1 cm in thickness.
The dose then attains its 100%o level on the skin.
Field sizes vary, but usually are of the order of a 6-cm circle. A tumour dose of 5,000-5,500 rads is delivered in three weeks.
A few patients have been treated by two fields with wedge filters and directed from the affected side. A similar volume is irradiated and the tumour dose remains the same as for the three field arrangement.
Material. -Between 1932 and 1958, 115 pathologically proved cases of carcinoma of the middle ear were seen at the Christie Hospital (Table 1 ). The following cases have been Further information is not available on those designated merely "carcinoma". The secondary carcinoma was metastatic to a primary in the breast; it was not treated.
Results.-The five-year results of all cases treated are shown in Table III (Table V) . The results at two years are shown of patients treated radically by beam directed X-rays, by the radium beam and by the 4 MV linear accelerator. The figure of 55% for the radium beam is from 11 cases only but represents a marked increase over the 300% obtained by 9 243 Manchester THE bladder is a relatively deep-seated organ, mainly surrounded by bone, lying in close relation to the other pelvic organs; moreover, tumours of the bladder are of limited radiosensitivity and require high doses if cure is to be obtained. Even with the use of elaborate multifield and rotational techniques, treatment with conventional 250-300 kV X-ray therapy is difficult and entails the production of severe reactions to deliver an adequate tumour dose. Before the introduction of the 4 MV linear accelerator, the majority of radical X-ray treatments of bladder tumours at the Christie Hospital were carried out on a 500 kV constant potential machine of H.V.L. 6-3 mm Cu. With this quality of X-irradiation, the bone shielding was significantly less than with conventional 250-300 kV irradiation and not greatly different from 4 MV irradiation. Even so, to deliver an adequate dose at the bladder required the use of a complex multifield treatment technique.
When introducing a new machine into routine clinical practice, the method of use will be influenced mainly by past experience with the
